Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
To shield the fetus, link a protein to these drugs
Why This Matters
This development highlights a promising approach to safeguarding fetal health by linking protective proteins to drugs, potentially reducing risks during pregnancy. It represents a significant step forward in pharmaceutical design, emphasizing safety and targeted delivery. For consumers and the industry, this could lead to safer medications for pregnant women and improved maternal-fetal health outcomes.
Key Takeaways
- Innovative drug modification to protect fetuses
- Enhanced safety in pregnancy-related medications
- Potential for broader applications in targeted drug delivery
Get alerts for these topics